Neurizon Therapeutics (FRA:ECQ0) Interest Paid : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics Interest Paid?

Neurizon Therapeutics's Interest Paid for the six months ended in Dec. 2024 was €0.00 Mil.

Neurizon Therapeutics's Interest Paid for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Neurizon Therapeutics Interest Paid Historical Data

The historical data trend for Neurizon Therapeutics's Interest Paid can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Interest Paid Chart

Neurizon Therapeutics Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun24

Interest Paid

Get a 7-Day Free Trial

-0.05

-0.07

-0.03

-0.02

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
Interest Paid	Get a 7-Day Free Trial															-0.03	-0.03	-	-	-

Neurizon Therapeutics Interest Paid Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Interest Paid represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Interest Paid for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Neurizon Therapeutics Interest Paid Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's Interest Paid provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » Interest Paid

Comparable Companies

Traded in Other Exchanges

NUZ:Australia

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.neurizon.com

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines